A plain language summary: an overview of objective (scientific) data and patient experiences showing how effective lemborexant is for treating insomnia

Plain Language SummaryWhat is this summary about?This is a summary of an article originally published in the journal Postgraduate Medicine. Insomnia is a sleep disorder where people have difficulty falling asleep and/or staying asleep. Nighttime symptoms of insomnia can cause troublesome daytime symptoms, such as difficulty thinking, fatigue, daytime sleepiness, behavioral or mood issues, and problems with work and/or social life. People usually seek help once their insomnia symptoms begin to impair their daily life. It is important that insomnia treatments improve both objective (measured with a test called polysomnography) and subjective (patient-reported) assessments of sleep. Researchers evaluated the effects of lemborexant, a medicine approved for the treatment of insomnia in adults, by assessing both objective and subjective measures of insomnia in 2 studies: SUNRISE-1 (Study 304) and SUNRISE-2 (Study 303).What did the researchers find?In both studies, participants taking lemborexant (5 mg or 10 mg) took less time to fall asleep, were awake for less time during the night, and spent more time sleeping than those taking placebo, as assessed by both objective and subjective measures of insomnia. Participants who took lemborexant reported less severe insomnia, fewer problems functioning during the day, and better quality of sleep than those who took placebo. In SUNRISE-2, participants who took lemborexant reported less tiredness than those who took placebo. As assessed at Month 6, more participants who took lemborexant (>67%) reported that the study drug had a positive effect on their sleep compared with those who took placebo (45%).What do the findings mean?Participants who took lemborexant experienced improved sleep without impaired next-day functioning compared with placebo, as assessed by objective (as measured with a test called polysomnography) and subjective (patient-reported) measures. These findings suggest that lemborexant is effective and may be a valuable treatment option for adults with insomnia.